Detalles de la búsqueda
1.
Efficacy and Safety of Programmed Death 1/Programmed Death-Ligand 1 Plus Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibitors for Advanced or Metastatic Non-Small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials.
Ther Drug Monit
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38840327
2.
The cardiac-related adverse events of PD-1/PD-L1 immunotherapy in advanced or metastatic lung cancer: a RCT-based meta-analysis.
Support Care Cancer
; 32(2): 140, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294563
Resultados
1 -
2
de 2
1
Próxima >
>>